A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines.
Putong, N; Agrupis, KA
; Villanueva, AM; Suzuki, S; Sayo, AR; Dimaano, E; de Guzman, F; Teaño, R; Salazar, MJ; Evangelista, JW; +5 more...Dimapilis, A; Villarama, JB; Ariyoshi, K; Takahashi, K; Smith, C and
(2022)
A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines.
The Lancet Regional Health - Western Pacific, 18.
100353-.
ISSN 2666-6065
DOI: 10.1016/j.lanwpc.2021.100353
; Villanueva, AM; Suzuki, S; Sayo, AR; Dimaano, E; de Guzman, F; Teaño, R; Salazar, MJ; Evangelista, JW; +5 more...Dimapilis, A; Villarama, JB; Ariyoshi, K; Takahashi, K; Smith, C and
(2022)
A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines.
The Lancet Regional Health - Western Pacific, 18.
100353-.
ISSN 2666-6065
DOI: 10.1016/j.lanwpc.2021.100353
Since the COVID-19 pandemic started in 2020, healthcare workers (HCW) and other hospital personnel have been regarded as “frontliners”, and at increased risk of SARS-CoV-2 infection compared to the general population. As such, testing only symptomatic individuals or regular testing of HCWs who directly attend to COVID-19 patients or specimens may underestimate the extent of infection, and actual SARS-CoV-2 seroprevalence. Because of this, the World Health Organization has called for seroepidemiological surveys to assess the extent of infection amongst HCW and other populations to provide timely estimates of COVID-19 virus infection severity and inform public health responses and evidence-based policy decisions.
-
picture_as_pdf - Putong_etal_2022_A-call-to-protect-non.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 4.0
Downloads